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The physiological control ofcellular proliferation and differentiation is an integrated regulatory process.
This conclusion isbased upon observations usingnumerous in vivo and in vitroexperimental systems ofwhich
murine BALB/c 3T3 Tmesenchymal stem cells represent anexcellent in vitromodel. In these cellsthe coup-
lingofgrowth arrest and differentiation occurs at a distinct biological state, and this predifferentiation ar-
rest state is distinguishable by a variety ofcriteria from other restriction points, such as the growth factor
deficiency arrest state andthe nutrientdeficiency arreststate. Most importantly, onlycells at thisprediffer-
entiation arrest state acquirethe potential todifferentiate withoutundergoingDNAsynthesis. Fromthis state,
differentiation can then occur as atwo-step process. Cells firstundergo nonterminal differentiation and, sec-
ond, theyterminally differentiate. Nonterminal differentiation is characterized byexpression ofa completely
differentiated adipocyte phenotype with retention ofproliferative potential. Thereafter, when nonterminally
differentiated cells undergo the terminal event in differentiation, theyirreversibly lose theirprolifertive poten-
tial. In this paper, data are reviewed which establish that the integrated control ofproliferation and differen-
tiation in 3T3 T mesenchymal stem cells is mediated both at thepredifferentiation arrest state and at the state
of nonterminal differentiation.
Introduction
To establish the mechanisms that regulate the in-
tegrated control ofproliferation and differentiation, mu-
rine BALB/c 3T3 T mesenchymal stem cells have been
used as amodelinvitro system. This stemcelllineisvalu-
able for avariety ofreasons. In contrast to most other cell
differentiation systems, such as the erythroleukemia,
neuroblastoma, melanoma, and embryonal carcinoma
cells that aretransformed(1-4), 3T3 T stem cells are non-
transformed with respect to the two-stage model ofcar-
cinogenesis (5,6). They therefore can be used for studies
on the mechanisms ofthe initiation andpromotion ofcar-
cinogenesis (6-11). This is true even though they are im-
mortal and aneuploid. Another valuable characteristic of
3T3 T stemcells is thattheypossess theability to differ-
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entiate and therein to integrally regulate the control ot
proliferation and differentiation under defined physio-
logical conditions. Somewhat similar biological charac-
teristics have also recently been reported in normal
diploid human keratinocyte progenitor cells (12-15).
3T3 Tmesenchymal stem cells are thoughtto be repre-
sentative of a variety of related cell lines including the
3T3-L1 (16), 3T3-F442A (17), 3T3-C2 (18), obl7 (19), and
(10T1/2)TAl(20). Whenundifferentiated, all suchcells have
afibroblastlike morphology, but when they differentiate
into specific celltypes, such as adipocytes, theymodulate
not only theirmorphology but also theirfunction. In this
regard, adipocytes werepreviously considered to be ter-
minally differentiated and therefore incapable ofprolifer-
ation and cell division. It has, however, now been estab-
lished that adipocytes aswell as some other differentiated
tissues can reproduce and undergo differentiation and
maturation (5-11,21,22). The general phenomena of cell
differentiation and the cellular and molecular changes
that occur during this process have been elucidated in
studies involving these excellent experimental systems
and in studies on differentiation into a variety ofmesen-FILIPAK ETAL.
chymal cell types, including adipocytes, striated muscle
cells, chondrocytes, vascular pericytes, and macrophages
(5,23,24).
In thispaper the observations that have beenmade con-
cerningthe differentiation of3T3T stem cells into adipo-
cytes will be reviewed, especially the processes involved
in the integrated regulation ofproliferation and differen-
tiation. The basis forthese studies was the development
of experimental methods to induce rapid and parasyn-
chronous differentiation ofthese cells into adipocytes at
low densityunderphysiological conditions ratherthan as
in other experimental systems wherein differentiation
typically requiresprolonged culture ofcells at ahigh den-
sity in high concentrations ofpathological fluids and/or
drugs. More specifically, in 3T3 T stem cells, differentia-
tion into adipocytes can be induced within 8 to 12 days
when cultured at < 1 x 104 cells/cm2 in Dulbecco's modi-
fied Eagle's medium (DME) containing 25% human
plasma and heparin on tissue culture plastic. It has re-
cently been found that culturing 3T3 T stem cells at a
similar low density in heparinized DME containing hu-
man plasma on nonadherent surfaces (bacteriological
Petri dishes) significantly accelerated the kinetics of
differentiation and therein more than 95% of the cells
differentiate within 5 to 7 days (25). Therefore, in 3T3
T stem cells, high cell density and extensive cell-to-cell
contact are notrequiredforadipocyte differentiation. Pro-
longed culture is also notrequiredforadipocyte differen-
tiation nor are high concentrations ofserum and/oradded
hormones, drugs, or chemicals.
With this model cell system it has been possible to
definitively establish the biological steps involved in the
integrated control ofproliferationand differentiation and
to show that this control process can be distinguished
from othermetabolic events that simplyblockcellgrowth.
Figure 1 presents a summary of the results of these
studies in diagrammatic form. It specifically demon-
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FIGURE 1. Model for the integrated control of3T3 Tmesenchymal stem
cellproliferation anddifferentiation(50). Themodelillustrates therela-
tive organization of the GD, GD', TD, Gs, and GN states in the GI
phase ofthe cell cycle as discussed in the text. GD, the predifferenti-
ation growth arrest state; GD', the nonterminal differentiation state;
TD, the terminal differentiation state; Gs, the reversible growth ar-
rest state inducedbygrowth factoror serumdeprivation; andGN, the
reversible growth arrest state induced by nutrient deprivation.
strates thatthree distinct steps are involved in the inte-
grated control ofproliferation and differentiation: predif-
ferentiation growth arrest, nonterminal differentiation,
and terminal differentiation. Each ofthese processes will




To understand thephysiological basisforthe control of
cell proliferation, most previous studies have focused on
events thatoccurintheGI phase ofthe cell cycle (26-31).
From these studies, it was concluded that there are one
or more specific restriction points in G, that control cell
proliferation. Extensive cell-cell contact or depletion of
growthfactorsorlowmolecularweightnutrientsfromthe
culture medium have been shown to induce transient/re-
versible growth arrest. A more physiological mechanism
to regulate cell proliferation, however, occurs in associ-
ation with the process ofcellular differentiation. This is
so because invivo stem cells regulate theirproliferation
in association with regulation oftheir differentiation.
The available evidence also suggests thatgrowth arrest
intheGI phase ofthe cell cycle isassociatedwith expres-
sion of the differentiated phenotype in many cell types
(28-30). These observations raise the questionofwhether
controlofboth cellproliferation and differentiation canbe
mediated at common statesintheG, phase ofthe cell cy-
cle. To resolve this initial question, 3T3T stemcells were
growth arrested at various states in GI and then tested
to determine whether differentiation could be induced
from all ofgrowth arrest states or only at a distinct ar-
rest state. To summarize theresults, therestriction ofcell
proliferation by high cell density, serum deprivation, or
nutrient deprivation does not support or facilitate the
differentiation of 3T3 T stem cells. Rather, these stem
cells mustgrowth arrest at adistinctcell cycle stateprior
to differentiation. (Studies onnormalhumankeratinocyte
progenitor cells also demonstrate the requirement for
predifferentiationgrowtharrest, butthey donot show as
stringent a cell-cycle specificity.)
Whenlowdensity, rapidlygrowing3T3T stemcells are
cultured in DME containinghumanplasma, theygrowth
arrest in G1 andremain in this state forapproximately 2
to 4 days (32). At this predifferentiation growth arrest
state, designatedGD, cells have thepotentialtoreinitiate
cell proliferation iftheyarerefed agrowthfactor-enriched
medium. Alternatively, ifthey arerefed ormaintained in
differentiation-promoting medium, up to 95% ofthe cells
convert to adipocytes within 3 to 8days dependingonthe
cells' microenvironment. In contrast, ifcells are growth
arrested at high density in serum containing DME or if
cells are growth arrested in agrowth factor-deficient or
nutrient-deficient medium at low cell densities, significant
differentiation does not occur even if such cultures are
refed differentiation-promoting medium so long as such
cells cannot traverse the cell cycle. Therefore, the
predifferentiationgrowth arrest state, GD, appears to rep-
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resent a distinct state in the GI phase ofthe cell cycle in
3T3 T stem cells.
The finding that differentiation occurs without DNA
synthesis in 3T3 T stem cells only at the predifferentia-
tiongrowth arrest stateis asignificant onebecause it sug-
gests that at this state specific sets of genes can be
preferentially regulated. Ib substantiate that quantal mi-
tosis and DNA synthesis are not required for adipocyte
differentiation, essentially pure populations ofundifferen-
tiated metaphase cells were isolated and subsequently
placed in differentiation-promoting media under condi-
tions thatrestricted their capacity to undergo DNA syn-
thesis and cell cycle traverse. Atleast80% of3T3 T stem
cells couldbe induced to differentiate by factors that act
solely in late M or G1 to activate the expression of
differentiation-specific genes. Thatis, underappropriate
microenvironmental conditions, metabolic events that oc-
cur solely in the late M or G1 phases ofthe cell cycle can
mediate the integrated control ofmesenchymal stem cell
proliferation and differentiation at the GD state.
Inthis regard, studies wereperformed to determine if
neoplastic transformation is associatedwith development
of a selective defect in one or more ofthe G, growth ar-
rest processes (33). Upon examining eight clones and
several uncloned tumorigenic 3T3T stem celllines, it was
initially shown that all the tumorigenic cell lines lacked
the ability to undergo predifferentiation growth arrest
andto differentiate, whereas some transformed cells did
retain the ability to growth arrest at low density when
deprived ofgrowthfactors and/ornutrients. More detailed
recent studies, however, have established that some trans-
formed 3T3 T stem cells can in fact differentiate even
though they do express significant defects in the strin-
gency oftheir differentiation regulatory mechanisms (8).
Infact, ithasbeen concludedthatcarcinogenesis isprob-
ably associated with the development of defects in the
stringencybywhichproliferation and differentiation are
integrally regulated. The characteristics ofthese defects
are also thought to determine whether a cancer is well
differentiated and slowgrowing orpoorly differentiated
and rapidly growing.
A variety of additional studies have been performed
comparing cells arrested at the GD, GS, and GN states (see
Fig. 1 for a definition ofthese terns). These studies all
substantiate the conclusion thatGD arrested cells are dis-
tinct by a variety ofcriteria, including the expression of
specific biochemical and morphological markers (Fig. 2).
Forexample, when scanningelectronmicroscopy was em-
ployed to examine the cell surface characteristics of3T3
T stem cells at various states in the G1 phase ofthe cell
cycle, predifferentiation growth arrested cells demon-
strated distinctlongcell surfacemicrovilli, which were not
observed in GS or GN arrested cells (34).
GD, GS, and GN arrest states were also distinguished in
their topography in G1. Kinetic studies were performed
to measure the time required for cells arrested at vari-
ous G1 states to initiate synthesis of DNA and to deter-
mine the ability ofthese growth arrested cells to convert
from one arrest state to another in the absence of DNA
synthesis. Relative to the start ofthe G1 phase ofthe cell
cycle, atopographical sequence was established inthefol-
lowing order: GD, GS, GN (35).
Cells at the predifferentiation growth arrest state are
also characterized bytheirunique sensitivity to themito-
genic effectofisobutyl methyl xanthine (MIX). Whenthe
relative ability of a variety of mitogens to induce DNA
synthesis ofcellsinthe GD andGS arrest stateswas com-
pared, cells atthe GD arrest state, regardless ofcell den-
sity, could be induced to proliferate by MIX treatment,
whereas cells at theGS arrest state atboth high and low
density could not be stimulated (36). Other characteris-
tics ofcells at the predifferentiation growth arrest state
not exhibited by GS- and GN-arrested cells include their
predilection toformextensive cell-cell clusters, ahigh sen-
sitivity to the cytotoxic effect of8-bromocyclic AMP(37),
andthe expressionofmorethan 100distinctpolypeptides
detected in two-dimensional gel electrophoretic analysis.
One ofthemostimportantquestions thatmust nowbe
resolved concerns the identification ofthe physiological
factors thatmediate predifferentiation growth arrest and
the underlying mechanisms that are involved. Although
suchfactors are yet tobepurified,preliminary studies in-
dicate that a specific protein factor(s) present in human
plasma and serum acts to induce growth arrest at the
predifferentiation arrest state, and this factor has tenta-
tivelybeendesignatedtheGDarrestor. Itisacidandheat
labile, trypsin sensitive, anddithiothreitol(LYTI)resistant.
Thisprotein(s) does notabsorb to an Affi-gel bluematrix,
but does bind to heparin agarose. Its isoelectric point is
< 7.0, with a molecular weight > 14,000. Interestingly,
the effects of this protein can be blocked by tumor
promoters such as TPA. Addition ofTPA (< 100 ng/mL)
to medium containing human plasma inhibits the induc-
tion ofpredifferentiation growth arrest.
In summary, these results suggest thatthe couplingof
growth arrest and differentiation can occur at a distinct
state in 3T3 T stem cells. Once cells arrest their growth
atthispredifferentiation state, they acquire thepotential
to differentiate ifthey are not first induced to reinitiate
proliferation by the addition of mitogenic factors. Thus,
predifferentiationgrowth arrestis apivotal statebecause
at this state cells either differentiate or reinitiate prolifer-
ation depending on the availability ofgrowth factors or
differentiation factors in the microenvironment.
Nonterminal Differentiation State
Once predifferentiation growth arrest has occurred,
what additional steps are involved in the process of
differentiation? Does asingle early event in the differen-
tiation process program cells to lose their proliferative
potential in association with differentiation, or does a sta-
ble nonterminal state ofdifferentiation exist? Manyprevi-
ous observations suggest that a state of nonterminal
differentiation does indeed exist in many cell types, but
an experimental model system to study this process has
beenlacking. Invivo studies oncardiacmyocytes andneu-
roblasts show that during development many cells that
are terminally differentiated in the adult animal actually




FIGURE 2. Phase-contrast micrographs of3T3 T mesenchymal stem cells at different growth vs. growth arrest states. Rapidly growing cells in 10%
FCS(A) cells atthepredifferentiationgrowth arrest state(GD) after4-day culture in 25% human plasma(B); cells at the growth factor deficiency
arrest state(GS) after4-dayculturein0.5% FCS(C); cells atthenutrientdeficiencygrowth arrest state(GN) after3-dayculture in isoleucine-deficient
DME containing 10% dialyzed FCS (D).
(38,39). Lymphocytes, liver cells, Schwann cells, and
smooth muscle cells are also all maintained in a nonter-
minally differentiated state forextendedperiods even in
adult tissues before terminal differentiation occurs
(40-43). Invitro studies also suggest that a nonterminal
differentiation state exists in some cell types. For exam-
ple, myoblaststhathavewithdrawnfromthe cellcycle and
express myosin can be induced to reenter the cell cycle
when exposed to growth media(44). Similar observations
have been reported in various neoplastic cells including
mast cells(45), melanomacells(46), erythroleukemiacells
exposed to hemin(1), andneuroblastoma cellsexposed to
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butyrate(47). Nonetheless, theprocess ofnonterminal dif-
ferentiation hasnotbeen studiedin detail norhasthe ter-
minal event in differentiation. 3T3 T stem cells were
therefore evaluated in this regard.
Experimental conditions were developed that limited
theterminal phase ofdifferentiation in 3T3 Tadipocytes
and thereby enrich cultures in nonterminally differen-
tiated cells. The culture oflow density 3T3 T stem cells
in heparinized DME containing aplasmafraction, desig-
nated citrate eluate of the barium-precipitated plasma
(CEPH), achieved this result (48,49). Such cultures first
underwent predifferentiation growth arrest, and flow
microfluorometric analysis showed these cells to have the
following cell cycle distribution: G1, 87%; S, 3%; G2/M,
10%. Thereafter, these cultures differentiated into adipo-
cytes that retained their proliferative potential for ex-
tended intervals and therefore exist in a nonterminally
differentiated state. Proofofthis was documented bythe
demonstration that 80 to 90% of such adipocytes were
capable ofundergoing DNA synthesis and clonalprolifer-
ation(Fig. 3). Inthe3T3Tmesenchymal stemcell system,
expression of the differentiated phenotype and loss of
proliferative potential are therefore separately controlled
processes; the expression ofthe differentiatedphenotype
is not sufficient to induce loss ofproliferative potential.
The development ofexperimental conditions to induce
and purify adipocytes atthe nonterminal states ofdiffer-
entiation is a significant one (48). While the previous in
vivo and in vitro studies mentioned above provided evi-
dence forthe existence ofanonterminally differentiated
state andthe transitionofsuch cellsto asubsequentter-
minal state ofdifferentiation, withthe3T3T stemceJl sys-
tem it has been possible to actually perform well-con-
trolled studies on the transition from nonterminal to
terminal states of differentiation. Thus, this model pro-
vides an excellent system to examine the separate and
specific controlprocesses associatedwith differentiation
perse andthose processes associated with loss ofprolifer-
ative potential. These will be discussed in the next sec-
tion of this review.
Numerous biochemical changes are associated with the
induction ofadipocyte differentiation. Theseinclude anin-
crease in theglucoseuptake and asignificantincrease in
the concentration of enzymes involved in lipogenesis.
These enzymesinclude lipoprotein lipase, fatty acid syn-
thetase, diacylglycerolacyltransferase, phosphatidic acid
phosphase, glycerol-3-phosphate dehydrogenase (G3PD),
andacetyl COAcarboxylase(16-21). Inthe 3T3 T cell sys-
tem, the specific expression ofthenonterminal adipocyte
phenotype has alsobeen shown to be associatedwiththe
accumulation ofintracellularlipiddroplets andincreased
activity ofG3PD andlipoprotein lipase(49). Infact, there
is a very good correlation in the kinetics ofnonterminal
differentiation using assays fortheactivity oflipoprotein
lipase, glycerol-3-phosphate dehydrogenase, andpresuma-
bly all otherlipogenic enzymes andmorphological assays.
The process of nonterminal differentiation can be in-
duced by a variety offactors includingproteins in blood
and various hormones. In addition, it can be modulated
byTGF-P(50). Thatis, while otherbiologically activepoly-
peptides, such as EGF, NGF, and somatomedin C, have
no specific effect on3T3 T adipocyte differentiation even
athigh concentrations, TGF-Pisapotentreversible inhib-
itor of adipocyte differentiation (50% inhibition at
0.06-0.08 ng/mL). TGF-f actually inhibits differentiation
in acell cycle-dependent mannerbyits effect onaspecific
phase ofthe differentiation process. Thatis, TGF-p blocks
the transition from the predifferentiation growth arrest
state to the nonterminal differentiation state.
Duringtheprocess ofnonterminal differentiation, cells
not only acquire a completely differentiated phenotype
but they also downregulate theirresponse togrowthfac-
tors. Thisphenomena doesnotpreventthe nonterminally
differentiated cellsfromproliferating; it simplyrequires
that theybe exposedto ahigh concentrationofappropri-
ate mitogens. For example, whereas predifferentiation
growth arrested cells can be induced to proliferate with
5% fetal calf serum (FCS), nonterminally differentiated
adipocytes require 30% FCS plus 50,Ag/mL insulin to ex-
press a maximum mitogenic response. The integrated
controlofcellproliferationand differentiationistherefore
mediated not only at the predifferentiation growth arrest
state but also at the nonterminal differentiation state.
Thisfindinganswersaquestionthatpreviouslyhas con-
founded investigators studyingthe control ofcell differen-
tiation. Do cells have to undergo a process designated
commitment prior to terminal differentiation? With re-
spect tothe3T3 Tmodel stem cell system, it appears that
there is no specific commitment step occurring that
makes cells differentiate terminally because neither re-
versible arrest at thepredifferentiation state nor nonter-
minaldifferentiationpredisposes cells subsequently to un-
dergo the terminal event in differentiation and thereby
lose their proliferative potential (24). Previous theories
proposingthatloss ofproliferative potential results from
an inhibitory effect of differentiation gene products on
DNA synthesis, oncellularproliferation, and/oron cell di-
vision therefore cannot hold true in these cells because
astable, nonterminally differentiated state clearly exists
andit canbe experimentally maintained andmodulated.
Ibreiterate, thecharacteristics ofadipocytes atthe non-
terminal state ofdifferentiation include: a) the potential
to make decisions to integrate the control ofdifferentia-
tionandproliferation; b)the expression ofafully differen-
tiated phenotype; c) the retention ofproliferative poten-
tial; and d) the expression ofdecreased responsiveness to
growth factors. In addition, nonterminally differentiated
adipocytes can be induced to dedifferentiate and subse-
quently redifferentiate into another cell type (23,24). That
is, studies have specifically demonstrated that nontermi-
nally differentiated adipocytes canbe induced to lose the
fat cell phenotype without undergoing DNA synthesis
when treated with retinoic acid, 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), ormethylisobutyl xanthine(48).
Such cells that have lost the adipocyte phenotype yet re-
main in the G, phase ofthe cell cycle and retain most of
the characteristics ofcells in predifferentiation growth ar-
rest thereafter become responsive to environmental in-
fluences that can further induce their redifferentiation
into adipocytes without DNA synthesis or theirprolifer-
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FIGURE 3. Phase-contrast micrographs of3T3 T mesenchymal stem cells at different differentiation states: adipocytes at the nonterminal differen-
tiation state(GD')(A)and adipocytes at theterminal differentiation state(TD)(B). Anautoradiograph ofadipocytes atthe nonterminal differenti-
ation state following incubation in 3H-thymidine to measure DNA synthesis is also illustrated (C). The figure shows that nonterminally differen-
tiated adipocytes can undergo DNA synthesis.
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ation and/or differentiation into another cell type (24).
In summary, the studiesreviewed demonstrate thatfol-
lowinggrowth arrest at the predifferentiation state, two
steps are involved in adipocyte differentiation. First, the
growth arrested cellsundergo nonterminal differentiation
wherein they develop anadipocyte morphologyyetretain
theirproliferative potential. Thereafter, terminal differen-
tiation occurs wherein differentiated cells specifically lose
theirproliferative potential. Mostimportant, these results
establish that the integrated control ofproliferation and
differentiation can be mediated at the nonterminal state
of differentiation.
Terminal Differentiation State
The control ofcellularproliferation is an important reg-
ulatory process. In normal stem cells, it appears to be
mediatedby abalance offorcesthat either stimulate pro-
liferation or stimulate nonterminal or terminal differenti-
ation. Most previous experimental studies on the control
ofcellularproliferation have examinedthemechanisms by
which DNA synthesis and cellular proliferation are ini-
tiated in quiescent cell populations. In related studies,
many growth factors and several growth inhibitory fac-
tors havebeencharacterized andpurified. Concerningthe
latter, these factors generally inhibit DNA synthesis
and/or cell proliferation in atransient, reversible manner.
Few studies have attempted to establish the mecha-
nisms by which a cell's proliferative potential can be ir-
reversibly limited in nonterminally differentiated cell
populations. The reason is because few, ifany, adequate
model cell systems have previously been developed
whereinnonterminally differentiated cells canberapidly
and parasynchronously induced to terminally differenti-
ate andirreversibly lose theirproliferative potentialwhen
exposed to aphysiological inducer. Inthisrespect, the3T3
T stem cell system provides an excellent model with
which to study the terminal event in cellular differentia-
tion. In this cell system, distinct nonterminal and termi-
nal states ofdifferentiation can beidentified, and transi-
tion from the nonterminal to the terminal states of
differentiation can be inducedby a component ofhuman
plasma (48,49).
What arethe characteristics ofthe terminal eventincel-
lular differentiation and how do nonterminal and termi-
nal cells differ? A series of biological, biochemical, and
molecular studies havebeenperformed to define as care-
fully aspossible the answertothese questions and to es-
tablish the mechanisms thatmediate the irreversible loss
of the proliferative potential.
Nonterminally and terminally differentiated popula-
tions of3T3 T adipocytes exhibit an essentially identical
morphology, they express similarlevels ofadipogenic en-
zymes, and they are similarly growth arrested in the GI
phase ofthe cell cycle (Fig. 3). A reasonable assumption
therefore isthatthey differonlyintheirproliferative ca-
pacity. Since such cells are very similar, studies were per-
formed to determine ifany protein differences between
these cells could be observed and whether these differ-
encesmightbe associated withloss ofproliferativepoten-
tial associated withtheterminal eventin differentiation.
By analysis ofsilver-stained two-dimensional gel electro-
phoretograms, averylimitednumberofdifferences in the
composition ofmajorproteins between nonterminally and
terminally differentiated adipocytes were indeed de-
tected. Out of more than 1000 protein spots evaluated,
only 6 were selectively expressed in terminally differen-
tiated cells; of these, 2 were localized to the cytoplasm,
and4werelocalized tothe nucleus(51). Another distinct
proteinwas selectivelyidentified inthe nucleusofnonter-
minally differentiated adipocytes.
Morerecently, three distinctbasicnuclearproteins have
been identified in nonterminally differentiated cells that
are selectively lost during the process of terminal
differentiation. Theseproteinswere identifiedbytheuse
ofcross-reactive monoclonal antibodies to heat shockpro-
tein90(unpublished observations). Additional studies are
currently in progress to further characterize the struc-
ture andfunction ofthese proteins as are experiments to
clone andcharacterize theirgenes. Inthisregard, itisim-
portant to note that these observations indicate that the
terminal event in the process ofmesenchymal stem cell
differentiation is probably associated with modulation in
the expression ofless than 1% ofthe major cytosolic and
nuclear proteins.
The significance ofthese differences in the expression
orabundance ofspecificproteins innonterminallyandter-
minally differentiated adipocytes is still an open question.
The differences couldbe due toprimary changes ingene
expression at the two states of differentiation or to
changes in the rate of protein synthesis/degradation.
Variations inposttranslational protein modification such
asglycosylationand/oracetylationmightalso accountfor
some ofthe observed differences. Posttranslational pro-
teinmodification viadifferentialphosphorylation is, how-
ever, notlikelytobe involved in thisprocess since signif-
icant differences were not observed in recent studies
evaluatingthe phosphoproteins in nonterminally and ter-
minally differentiated adipocytes (unpublished observa-
tions). Themostsignificant questionthatmustnowbe re-
solved concernswhich specificproteinsfunction to control
cellularproliferation andhowtheycanirreversibly cause
cells to lose proliferative potential.
It is also important to establish which proteins in hu-
man plasma actually induce transition from the nonter-
minal to terminal state of differentiation. This goal has
beenpartially achieved by the 20,000-foldpurification of
a component ofhumanplasma that induces the terminal
eventin adipocyte differentiation(52). Thisfactorhas an
apparent molecular weight of45,000 daltons and an iso-
electric point ofapproximately 7.6. It is trypsin sensitive,
acid and heat labile, and is resistant to treatment with
dithiothreitol andalkali. The ability ofthis humanplasma
protein to induce the irreversible loss of proliferative
potential associated with the terminal event in adipocyte
differentiation serves as the basis for its designation
"aproliferin" (52). In this regard, none ofthe more than
20pharmacologic orphysiologic agents thathave been ex-
amined canmimicthebiologiceffectofaproliferin. There-
fore, it appears that aproliferin is a functionally distinct
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protein that can convert nonterminal adipocytes to ter-
minal adipocytes within 12 hr of exposure. The mecha-
nismbywhich aproliferin mediates this effectis, however,
stillunderinvestigation. Experiments arealsoinprogress
to prepare anti-aproliferin monoclonal antibodies, to se-
quence aproliferin, and to clone the gene for this poten-
tially important protein.
Additional studies have furthermore established that
the terminal event in differentiation also can be reversi-
bly inhibited by tumor necrosis factor (TNF). That is,
whereas TGF-P selectively inhibits the transition from
predifferentiation growth arrest to nonterminal differen-
tiation, TNF selectively inhibits the transition from non-
terminal differentiation to terminal differentiation (un-
published observations). Evidence hasalsobeenobtained
that suggests that aberrant 3T3 T stem cell clones that
cannot terminallydifferentiate actually secrete molecules
that function in a manner similar to TNF to block their
ownterminal differentiation in anautocrine and/orpara-
crine manner.
Tb summarize, adipocytes that undergo the terminal
event in differentiation are characterized by two most im-
portant features. They cannot reinitiate proliferation nor
can they be induced to lose their adipocyte phenotype.
Duringterminal differentiation, adipocytes appear to ac-
quire six distinct polypeptides not present in nontermi-
nally differentiated cells andtolose atleastfourproteins
that are present in nonterminally differentiated adipo-
cytes. It also appears that these changes are induced by
exposure ofcells to aproliferin. By definition, terminally
differentiated cells therefore do not mediate any aspect
ofthe integrated control ofproliferation and differentia-
tion because they cannot modify their differentiation nor
proliferation even though they are viable cells.
Resume and Speculation
Figure 1 again summarizes the results of our studies
that establish the biological processes by which 3T3 T
mesenchymal stem cells integrally regulate control of
theirproliferation anddifferentiation. The data showthat
in these stem cells multiple cell cycle restriction points
exist but that the integrated control ofproliferation and
differentiation is mediated only at a distinctpredifferen-
tiation growth arrest state and at the state ofnontermi-
nal differentiation. The results also define the characteris-
tics of these states and the fact that nonterminally
differentiated cells can be specifically induced to undergo
the terminal event in differentiation following exposure
to the human plasma protein designated aproliferin.
A series ofadditional questions nowneed toberesolved
specifically concerning whether all multipotential stem
cells demonstrate regulatorymechanisms comparable to
3T3 T mesenchymal stem cells and/or whether progeni-
tor cells show a different regulatory mechanism. Al-
though ourmodel for the integrated control ofprolifera-
tion and differentiation in 3T3 T stem cells has been
confirmed in studies on neural cells (53), myogenic cells
(54), andembryonal carcinomacells(4), we speculatethat
some cell types may have evolved somewhat distinctreg-
ulatory mechanisms. We also speculate that progenitor
cells that have a more restricted differentiation and/or
proliferation potential may in fact be found to integrally
regulate proliferation and differentiation in a distinct
manner.
The challenge forthefuture is to clearly define the op-
tions cells have to control theirproliferation and differen-
tiation and to determine what specific defects in these
regulatorymechanisms occur during carcinogenesis and
other disease processes.
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